The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left ventricular (LV) traits (19,260 UK Biobank participants with structurally normal hearts). We identified 16 loci associated with HCM, 13 with DCM and 23 with LV traits. We show strong genetic correlations between LV traits and cardiomyopathies, with opposing effects in HCM and DCM. Two-sample Mendelian randomization supports a causal association linking increased LV contractility with HCM risk. A polygenic risk score explains a significant portion ...
BackgroundEach of the cardiomyopathies, classically categorized as hypertrophic cardiomyopathy, dila...
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
Background: Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventri...
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes o...
Background Inherited cardiomyopathies display variable penetrance and expression, and a component of...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Importance Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young peo...
Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac muscle whose genetic basis has...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian dis...
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF...
Heart failure is highly influenced by heritability, and nearly 100 genes link to familial cardiomyop...
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, cause...
Aims: Dilated cardiomyopathy (DCM) is a major cause of heart failure with a high familial recurren...
BackgroundEach of the cardiomyopathies, classically categorized as hypertrophic cardiomyopathy, dila...
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
Background: Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventri...
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes o...
Background Inherited cardiomyopathies display variable penetrance and expression, and a component of...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Importance Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young peo...
Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac muscle whose genetic basis has...
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic vari...
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian dis...
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF...
Heart failure is highly influenced by heritability, and nearly 100 genes link to familial cardiomyop...
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, cause...
Aims: Dilated cardiomyopathy (DCM) is a major cause of heart failure with a high familial recurren...
BackgroundEach of the cardiomyopathies, classically categorized as hypertrophic cardiomyopathy, dila...
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
Background: Left ventricular maximum wall thickness (LVMWT) is an important biomarker of left ventri...